Fatemeh Ardeshir, MD, MSc

Biography

Board certified in internal medicine, hematology and medical oncology, Dr. Ardeshir`s primary clinical focus is thoracic oncology including lung cancer, mesothelioma and thymic tumors.

Dr. Ardeshir is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute of Emory University. She is also one of the ECOG-ACRIN trial investigator.

Titles & Roles

• Assistant Professor, Department of Hematology and Medical Oncology

  Emory University School of Medicine

Education & Training

Education

• Fellowship, Hematology/Oncology, 2023

  Indiana University School of Medicine
• Residency, Internal Medicine, 2020

  Case Western Reserve School of Medicine
• Internship, 2014

  Tehran University of Medical Sciences
• Medical Education, MD, 2012

  Tehran University of Medical Sciences

Board Certifications

• Hematology

  American Board of Internal Medicine, 2023
• Medical Oncology

  American Board of Internal Medicine, 2023
• Internal Medicine

  American Board of Internal Medicine, 2020

Professional Memberships

• President of the American Society of Clinical Oncology (ASCO) International Medical Graduates Research and Publication Committee
• International Association for the Study of Lung Cancer's Rare Tumor Committee (IASLC)
• American Association for Cancer Research (AACR)
• Society for Immunotherapy of Cancer (SITC)
• International Thymic Malignancy Interest Group (ITMIG)

Research

Dr. Ardeshir's scholarly and research activities are on new target discovery and defining an immune resistance mechanism in lung cancer. She also has clinical and research interests in thymic epithelial tumors.

Publications

Dr. Ardeshir has been published in several leading journals including New England Journal of Medicine, Clinical Lung Cancer, JCO-Precision Oncology, JCO-Oncology Practice, Lung Cancer Journal and Nature Review Clinical Oncology.

Awards

Dr. Ardeshir is the recipient of the following awards and honors:

• Prevent Cancer Foundation grant award (Co-PI), 2024
• Discovery Grant Award, The Fund for Innovation in Cancer Informatics, 2024
• Young Investigator Award in Translational Research, ECOG-ACRIN, 2023
• Career Advancement Award, Binaytara Foundation, 2023
• American Philosophical Society fellowship grant award, 2023
• ASCO Merit Award, 2021
• Career Development Alumni Award, Indiana University, 2021
• American Society of Clinical Oncology Mentoring Reviewing Program Scholar, ASCO, 2020
• Department of Medicine Research Award, Case Western Reserve University, 2019

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.